Navigation Links
Mutated Gene Zaps Pancreas Cancer in Mice

A mutated gene named Bik can shrink or kill tumors in the pancreas of mice, US researchers said in a study published Monday, offering hope for one of the deadliest human cancers

The mutant gene named Bik expresses a protein that forces cancer cells to kill themselves, researchers from The University of Texas MD Anderson Cancer Center said.

The team even created a more lethal mutant, called BikDD, which spares healthy tissue.

"There are no good options for pancreatic cancer patients now," said James Abbruzzese, professor and chair of MD Anderson Department of Gastrointestinal Oncology.

Two types of mice were treated after they were infected with two aggressive lines of pancreatic cancer, one in a very advanced stage.

Infected control mice in both groups died within 40 days without treatment, while at least half those who received the aggressive BikDD mutant gene survived for 14 months with no signs of cancer.

"This vehicle, or vector, is so targeted and robust in its cancer-specific expression that it can be used for therapy and perhaps for imaging" that could lead to early cancer detection, said Mien-Chie Hung, professor and chair of Anderson center and senior author of the study.

"This looks like a promising approach to gene therapy for pancreatic cancer and we are working to bring it to a clinical trial," said Abbruzzese.

He estimated it will take between one and two years to complete US Food and Drug Administration requirements for Phase I clinical trial in humans. The side effects in mice were mild, they said, which is rare for cancer treatments.

Pancreatic cancer kills 96 percent of human victims within five years of diagnosis, one of the lowest cancer survival rates.

Some 37,000 cases of pancreatic cancer are diagnosed annually in the United States. Early diagnosis is extremely difficult, so the disease is often discovered at a late stage after it has already spread, or metastasized. br>

'"/>




Related medicine news :

1. Mutated Viruses Can Cure Tumors
2. Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias
3. Mutated Gene and Bad Habits can Lead to Age-related Macular Degeneration
4. Pancreas transplant gives hope to type 2 diabetes
5. Pancreas Transplant for Diabetics
6. Stomach Bruises Can Lead To Pancreas Infection
7. Once-Diabetic Heart/Kidney/Pancreas Transplant Recipient Enjoys Life (And Eating Again)
8. Fibroids unlikely to Turn Cancerous
9. Virus Level could Predict Cervical Cancer Risk
10. Cancer Doctors Okays Controversial Prostate Therapy
11. Potential New Cancer Gene Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... St. Louis, Missouri (PRWEB) , ... April 26, ... ... optimal cost, quality and clinical outcomes, today released the podcast, “Make Plans ... Act in bringing value-based payment into the physician's office and how physicians and ...
(Date:4/26/2017)... N.J. (PRWEB) , ... April 26, 2017 , ... ... Inc. in Hackensack, N.J. has been honored by Enterprising Women magazine as ... that recognizes the world’s top women business owners. Winners have demonstrated that they ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant ... produce more and better food, with fewer resources. It highlights the business’ principles, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
Breaking Medicine Technology: